Catheter Precision (VTAK) Projected to Post Quarterly Earnings on Thursday

Catheter Precision (NYSEAMERICAN:VTAK) is anticipated to issue its quarterly earnings data on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.20) per share and revenue of $0.28 million for the quarter.

Catheter Precision Price Performance

NYSEAMERICAN VTAK opened at $0.39 on Thursday. Catheter Precision has a fifty-two week low of $0.30 and a fifty-two week high of $8.40. The company has a current ratio of 0.66, a quick ratio of 0.65 and a debt-to-equity ratio of 0.12. The stock’s fifty day moving average is $0.41.

Catheter Precision Company Profile

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.